| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910140853503321 |
|
|
Autore |
Lévy David |
|
|
Titolo |
Practical diabetes care [[electronic resource] /] / David Levy |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford, : Wiley-Blackwell, 2011 |
|
|
|
|
|
|
|
ISBN |
|
1-283-51424-9 |
9786613826695 |
1-4443-9114-3 |
1-4443-9115-1 |
1-4443-9113-5 |
|
|
|
|
|
|
|
|
Edizione |
[3rd ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (338 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Diabetes - Treatment |
Primary care (Medicine) |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Practical Diabetes Care; Contents; Preface; Numbers, conversions and tables; 1 Classification and diagnosis; Introduction; Classification; Diagnosis of diabetes in non-pregnant adults; IGT and clinical trials to prevent progression of IGT to diabetes; Screening for diabetes; Prevention of type 1 diabetes; References; Further reading; 2 Diabetes in the emergency department; Introduction; Hyperglycaemic emergencies: diabetic ketoacidosis and hyperglycaemic hyperosmolar state; Management of the clinically well, newly presenting type 1 patient; Precipitating factors; Ketones in DKA |
Intensive care unit?Investigations; Management; Follow-up; Hypoglycaemia; The acute diabetic foot; References; Further reading; 3 Management of inpatient diabetes; Introduction; Acute coronary syndromes (ST-segment elevation acute myocardial infarction, non-ST-segment elevation acute myocardial infarction and unstable angina); Atrial fibrillation; Patients in the intensive care unit; Non-critically ill patients; Stroke; Enteral feeding (nasogastric, percutaneous endoscopic gastrostomy); Glucocorticoid treatment; Inpatient screening routine; Perioperative management; References |
|
|
|
|
|
|
|
|
|
|
|
Further reading4 Type 1 diabetes: insulin treatment; Introduction; Total daily insulin dose requirements; Glycaemic targets in type 1 diabetes; Insulin products; Insulin prescribing; Insulin preparations; Basal-bolus/multiple-dose insulin; Biphasic (fixed-ratio) mixtures; Insulin pump treatment (CSII); Checklist of practical points whenever there is a problem with blood glucose control; Continuous glucose monitoring; New developments; References; Further reading; 5 Type 2 diabetes: general introduction; Introduction: type 2 diabetes as a progressive condition |
The general approach to the newly diagnosed type 2 patientLifestyle intervention: diet and exercise; Drug treatment of type 2 diabetes; References; Further reading; 6 Type 2 diabetes: pharmacological treatment of hyperglycaemia; Introduction; Metformin (British National Formulary, Section 6.1.2.2); Sulphonylureas and meglitinides (prandial insulin regulators) (British National Formulary, Section 6.1.2.1); Thiazolidinediones (glitazones) (British National Formulary, Section 6.1.2.3); α-Glucosidase inhibitors (British National Formulary, Section 6.1.2.3) |
Drugs acting on the incretin system (entero-insular axis)DPP-4 inhibitors (gliptins) (British National Formulary, Section 6.1.2.3); Pramlintide; Combination non-insulin treatment; Insulin treatment in type 2 diabetes; New developments; References; Further reading; 7 Infections in diabetes; Introduction; Types of infections; Chest infections; Infections after surgery; Urinary tract infections (British National Formulary, Section 5.1.13); Abdominal infections; Soft-tissue infections; Diabetic foot infections; Uncommon infections characteristic of diabetes; References; Further reading |
8 Diabetic renal disease |
|
|
|
|
|
|
Sommario/riassunto |
|
"Diabetes is the catalyst for a whole host of chronic complications that can appear as a result of the disease, such as: diabetic retinopathy, diabetic neuropathy, foot ulcers, kidney failure, and an increased risk of heart disease and stroke. Diabetes management is changing rapidly, and powerful new agents, including some that may modify the natural history of diabetes and its complications, continue to be introduced, as both Type 1 and Type 2 diabetes increase in prevalence and impact worldwide. This brief guide summarizes the specific information needed for clinical treatment of diabetic patients"--Provided by publisher. |
|
|
|
|
|
|
|
| |